511 related articles for article (PubMed ID: 36951060)
1. METTL3 (Methyltransferase Like 3)-Dependent N6-Methyladenosine Modification on
Li Q; Yu L; Gao A; Ren R; Zhang J; Cao L; Wang X; Liu Y; Qi W; Cai L; Li W; Wang W; Guo X; Su G; Yu X; Zhang J; Xi B; Zhang Y; Zhang M; Zhang C
Arterioscler Thromb Vasc Biol; 2023 May; 43(5):755-773. PubMed ID: 36951060
[TBL] [Abstract][Full Text] [Related]
2. m6A-related bioinformatics analysis and functional characterization reveals that METTL3-mediated NPC1L1 mRNA hypermethylation facilitates progression of atherosclerosis via inactivation of the MAPK pathway.
Zhang G; Li X; Huang X
Inflamm Res; 2023 Mar; 72(3):429-442. PubMed ID: 36583755
[TBL] [Abstract][Full Text] [Related]
3. Mettl3 promotes oxLDL-mediated inflammation through activating STAT1 signaling.
Li Z; Xu Q; Huangfu N; Chen X; Zhu J
J Clin Lab Anal; 2022 Jan; 36(1):e24019. PubMed ID: 34825733
[TBL] [Abstract][Full Text] [Related]
4. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
Feng Z; Li Q; Meng R; Yi B; Xu Q
J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
[TBL] [Abstract][Full Text] [Related]
5. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
Xie W; Ma LL; Xu YQ; Wang BH; Li SM
Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
[TBL] [Abstract][Full Text] [Related]
6. Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis.
Sun Z; Chen W; Wang Z; Wang S; Zan J; Zheng L; Zhao W
Clin Immunol; 2022 Dec; 245():109176. PubMed ID: 36368640
[TBL] [Abstract][Full Text] [Related]
7. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
8. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
9.
Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
[No Abstract] [Full Text] [Related]
10. Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanism.
Ni WJ; Zhou H; Lu H; Ma NN; Hou BB; Li W; Kong FX; Yu JT; Hou R; Jin J; Wen JG; Zhang T; Meng XM
Clin Transl Med; 2023 Aug; 13(8):e1359. PubMed ID: 37537731
[TBL] [Abstract][Full Text] [Related]
11. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer.
Yue B; Song C; Yang L; Cui R; Cheng X; Zhang Z; Zhao G
Mol Cancer; 2019 Oct; 18(1):142. PubMed ID: 31607270
[TBL] [Abstract][Full Text] [Related]
12. METTL3-Mediated N6-Methyladenosine Methylation Modifies Foxp3 mRNA Levels and Affects the Treg Cells Proportion in Peripheral Blood of Patients with Asthma.
Fan L; Wu J; Wang H; Chen Q; He X; Wang Q; Yang Z
Ann Clin Lab Sci; 2022 Nov; 52(6):884-894. PubMed ID: 36564065
[TBL] [Abstract][Full Text] [Related]
13. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
14. METTL3-dependent N
Chien CS; Li JY; Chien Y; Wang ML; Yarmishyn AA; Tsai PH; Juan CC; Nguyen P; Cheng HM; Huo TI; Chiou SH; Chien S
Proc Natl Acad Sci U S A; 2021 Feb; 118(7):. PubMed ID: 33579825
[TBL] [Abstract][Full Text] [Related]
15. RNA-m6A modification of HDGF mediated by Mettl3 aggravates the progression of atherosclerosis by regulating macrophages polarization via energy metabolism reprogramming.
Zheng L; Chen X; Yin Q; Gu J; Chen J; Chen M; Zhang Y; Dong M; Jiang H; Yin N; Chen H; Li X
Biochem Biophys Res Commun; 2022 Dec; 635():120-127. PubMed ID: 36265285
[TBL] [Abstract][Full Text] [Related]
16. Exploration of N6-Methyladenosine Profiles of mRNAs and the Function of METTL3 in Atherosclerosis.
Zhou Y; Jiang R; Jiang Y; Fu Y; Manafhan Y; Zhu J; Jia E
Cells; 2022 Sep; 11(19):. PubMed ID: 36230944
[TBL] [Abstract][Full Text] [Related]
17. METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications.
Jian D; Wang Y; Jian L; Tang H; Rao L; Chen K; Jia Z; Zhang W; Liu Y; Chen X; Shen X; Gao C; Wang S; Li M
Theranostics; 2020; 10(20):8939-8956. PubMed ID: 32802173
[No Abstract] [Full Text] [Related]
18. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
19. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
[TBL] [Abstract][Full Text] [Related]
20. Silencing METTL3 Stabilizes Atherosclerotic Plaques by Regulating the Phenotypic Transformation of Vascular Smooth Muscle Cells via the miR-375-3p/PDK1 Axis.
Chen J; Lai K; Yong X; Yin H; Chen Z; Wang H; Chen K; Zheng J
Cardiovasc Drugs Ther; 2023 Jun; 37(3):471-486. PubMed ID: 35704246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
